Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Medtronic
McKesson
Teva
Moodys
Mallinckrodt
Harvard Business School
Federal Trade Commission
Farmers Insurance

Generated: October 18, 2017

DrugPatentWatch Database Preview

Quetiapine fumarate - Generic Drug Details

« Back to Dashboard

What are the generic sources for quetiapine fumarate and what is the scope of quetiapine fumarate patent protection?

Quetiapine fumarate
is the generic ingredient in three branded drugs marketed by Lupin Ltd, Alkem Labs Ltd, West-ward Pharms Int, Mylan Pharms Inc, Intellipharmaceutics, Astrazeneca Pharms, Teva Pharms, Astrazeneca, Jubilant Generics, Accord Hlthcare, Macleods Pharms Ltd, Pharmadax Inc, Apotex Inc, Actavis Grp Ptc, Torrent Pharms Ltd, Unichem Labs Ltd, Sandoz, Dr Reddys Labs Ltd, Par Pharm, Aurobindo Pharma Ltd, Alembic Pharms Ltd, and Sun Pharma Global, and is included in twenty-five NDAs. There is one patent protecting this compound and seven Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are fifty-one drug master file entries for quetiapine fumarate. Fifty-three suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: quetiapine fumarate

US Patents:1
Tradenames:3
Applicants:22
NDAs:25
Drug Master File Entries: see list51
Suppliers / Packagers: see list53
Bulk Api Vendors: see list107
Clinical Trials: see list795
Patent Applications: see list4,688
Therapeutic Class:Bipolar Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:quetiapine fumarate at DailyMed

Pharmacology for Ingredient: quetiapine fumarate

Tentative approvals for QUETIAPINE FUMARATE

Applicant Application No. Strength Dosage Form
u► Subscribe50MGTABLET, EXTENDED RELEASE; ORAL
u► Subscribe400MGTABLET, EXTENDED RELEASE; ORAL
u► Subscribe300MGTABLET, EXTENDED RELEASE; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic Pharms Ltd
QUETIAPINE FUMARATE
quetiapine fumarate
TABLET;ORAL203390-004Oct 28, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Macleods Pharms Ltd
QUETIAPINE FUMARATE
quetiapine fumarate
TABLET;ORAL203359-001May 17, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alembic Pharms Ltd
QUETIAPINE FUMARATE
quetiapine fumarate
TABLET;ORAL203390-006Oct 28, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
QUETIAPINE FUMARATE
quetiapine fumarate
TABLET;ORAL077745-006Mar 27, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Macleods Pharms Ltd
QUETIAPINE FUMARATE
quetiapine fumarate
TABLET;ORAL203359-003May 17, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
QUETIAPINE FUMARATE
quetiapine fumarate
TABLET;ORAL201504-005Feb 12, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
QUETIAPINE FUMARATE
quetiapine fumarate
TABLET;ORAL201504-003Feb 12, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Unichem Labs Ltd
QUETIAPINE FUMARATE
quetiapine fumarate
TABLET;ORAL202674-003Mar 8, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
QUETIAPINE FUMARATE
quetiapine fumarate
TABLET;ORAL090960-005Mar 27, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Pharmadax Inc
QUETIAPINE FUMARATE
quetiapine fumarate
TABLET, EXTENDED RELEASE;ORAL206260-004May 9, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: quetiapine fumarate

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Cantor Fitzgerald
Dow
Covington
Queensland Health
Accenture
Colorcon
Daiichi Sankyo
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot